| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 25/02/2025 | 23:23 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:QTRX | Quanterix Corporation |
| 25/02/2025 | 23:22 | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business combinations | NASDAQ:QTRX | Quanterix Corporation |
| 19/02/2025 | 22:13 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:QTRX | Quanterix Corporation |
| 18/02/2025 | 21:40 | Business Wire | Kent Lake Issues Letter to Quanterix Shareholders Regarding Opposition to the Company’s Proposed Merger with Akoya Biosciences | NASDAQ:QTRX | Quanterix Corporation |
| 14/02/2025 | 12:28 | Edgar (US Regulatory) | Form S-4 - Registration of securities, business combinations | NASDAQ:QTRX | Quanterix Corporation |
| 13/02/2025 | 19:45 | Edgar (US Regulatory) | Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership | NASDAQ:QTRX | Quanterix Corporation |
| 28/01/2025 | 15:23 | PR Newswire (US) | Kuehn Law Encourages LGTY, QTRX, RDW, and AZPN Investors to Contact Law Firm | NASDAQ:QTRX | Quanterix Corporation |
| 14/01/2025 | 13:00 | Business Wire | Quanterix Provides Update on Financial Performance | NASDAQ:QTRX | Quanterix Corporation |
| 10/01/2025 | 13:00 | Business Wire | Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers | NASDAQ:QTRX | Quanterix Corporation |
| 06/01/2025 | 15:30 | Business Wire | David R. Walt Receives National Medal of Technology and Innovation | NASDAQ:QTRX | Quanterix Corporation |
| 02/01/2025 | 22:26 | Business Wire | Quanterix to Present at the 43rd Annual J.P. Morgan Healthcare Conference | NASDAQ:QTRX | Quanterix Corporation |
| 17/12/2024 | 12:59 | Business Wire | Quanterix Expands Capabilities with Strategic Acquisition of EMISSION | NASDAQ:QTRX | Quanterix Corporation |
| 22/11/2024 | 23:00 | Business Wire | Quanterix Announces Receipt of Expected Notice from Nasdaq | NASDAQ:QTRX | Quanterix Corporation |
| 13/11/2024 | 22:01 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB | NASDAQ:QTRX | Quanterix Corporation |
| 12/11/2024 | 22:01 | Business Wire | Quanterix Releases Preliminary Financial Results for the Third Quarter of 2024 | NASDAQ:QTRX | Quanterix Corporation |
| 05/11/2024 | 22:00 | Business Wire | Quanterix To Report Third Quarter 2024 Financial Results on November 12, 2024 | NASDAQ:QTRX | Quanterix Corporation |
| 28/10/2024 | 21:30 | Business Wire | New Multi-Marker Blood Test from Lucent Diagnostics Increases the Number of Patients Receiving Early Alzheimer’s Disease Diagnostic Information | NASDAQ:QTRX | Quanterix Corporation |
| 04/10/2024 | 13:07 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] | NASDAQ:QTRX | Quanterix Corporation |
| 02/10/2024 | 22:00 | Business Wire | Quanterix Welcomes Ivana Magovčević-Liebisch, Ph.D., J.D. to Board of Directors | NASDAQ:QTRX | Quanterix Corporation |
| 30/09/2024 | 22:00 | Business Wire | Quanterix Announces Commercialization of p-Tau 217 Test Kit | NASDAQ:QTRX | Quanterix Corporation |
| 29/08/2024 | 22:00 | Business Wire | Quanterix to Participate at the Morgan Stanley 22nd Annual Global Healthcare Conference | NASDAQ:QTRX | Quanterix Corporation |
| 21/08/2024 | 22:29 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NASDAQ:QTRX | Quanterix Corporation |
| 19/08/2024 | 22:32 | Business Wire | Jeffrey Elliott Appointed to Quanterix’s Board of Directors | NASDAQ:QTRX | Quanterix Corporation |
| 16/08/2024 | 12:03 | IH Market News | Deutsche Bank Faces Shareholder Backlash, Bank of America Sponsors 2026 World Cup, Quanterix CEO Buys More Shares | NASDAQ:QTRX | Quanterix Corporation |
| 08/08/2024 | 22:59 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:QTRX | Quanterix Corporation |
| 08/08/2024 | 22:00 | Business Wire | Quanterix Releases Financial Results for the Second Quarter of 2024 | NASDAQ:QTRX | Quanterix Corporation |
| 06/08/2024 | 22:00 | Business Wire | Quanterix Presenting at Canaccord Genuity 44th Annual Growth Conference | NASDAQ:QTRX | Quanterix Corporation |
| 31/07/2024 | 22:00 | Business Wire | Quanterix To Report Second Quarter 2024 Financial Results | NASDAQ:QTRX | Quanterix Corporation |
| 29/07/2024 | 14:00 | Business Wire | Quanterix Presents Data Demonstrating Successful Multi-Marker Approach for Alzheimer’s Disease Detection that is More Effective than Standalone Plasma p-Tau 217 | NASDAQ:QTRX | Quanterix Corporation |
| 17/06/2024 | 22:00 | Business Wire | Quanterix to Participate at the Scotiabank Healthcare 1x1 Day | NASDAQ:QTRX | Quanterix Corporation |
